Gradient Investments’s Biodesix BDSX Stock Holding History

Gradient Investments’s Portfolio BDSX Stock Details BDSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-5	Closed	-$123	–	1814
2023 Q2	$123	Buy	+5	New	+$150	﹤0.01%	1671

Other funds holding BDSX

Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return

ACM

AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

WVP

Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EIM

Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

LCM

Legato Capital Management San Francisco, California $1.1B AUM 61.65% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Gradient Investments's BDSX Position: Q3 2023 in Review

Gradient Investments sold out of Biodesix (BDSX) in Q3 2023, closing a stake of 5 shares — an estimated $123 sold.

Gradient Investments first reported a position in BDSX in Q2 2023 and held it in 1 quarter. The position peaked at $123 in Q2 2023. 37 funds tracked by Wall St. Rank hold BDSX as of Q3 2023.

Gradient Investments reported no remaining Biodesix position as of Q3 2023 after selling out during the quarter.
Gradient Investments sold 5 Biodesix shares in Q3 2023, an estimated $123.
Gradient Investments first reported a position in Biodesix in Q2 2023 and held it in 1 quarter.
Gradient Investments's Biodesix position peaked at $123 in Q2 2023.
37 funds tracked by Wall St. Rank held Biodesix as of Q3 2023.

Based on Gradient Investments's 13F filing for Q3 2023, filed 27 Oct 2023.